Particle.news

Download on the App Store

Supreme Court to Hear Case on Abortion Pill Access After Roe v. Wade Reversal

The court's decision could significantly impact reproductive healthcare, amid ongoing legal and political battles over abortion rights.

  • The Supreme Court will hear its first abortion case since the reversal of Roe v. Wade, focusing on the FDA's rules for access to the abortion pill mifepristone.
  • Fourteen states have total bans and seven others have substantial restrictions on abortion access, affecting the availability of abortion medication.
  • The Biden administration defends the FDA's assessment of mifepristone, emphasizing its safety and effectiveness over two decades.
  • Abortion pills, particularly mifepristone, have become the most common method of ending pregnancies in the U.S., with a significant increase in use via telehealth.
  • Legal and political battles over abortion rights and access to abortion medication continue, with significant implications for reproductive healthcare in the U.S.
Hero image